




Pharma & Healthcare Monitor Worldwide
September 29, 2023 Friday


Copyright 2023 Global Data Point. Provided by Syndigate Media Inc. All Rights Reserved


Length: 283 words
Body


(GlobeNewswire) - Signati Medical is pleased to announce the issue of US patent 11,723,680 covering critical features of the bipolar handpiece used in Signatis Sealed Vasectomy Procedure (SVP).
The handpiece patent and the vasectomy method patents expire in 2039. An additional method patent with expanded coverage is pending.
Signatis patent portfolio also includes patents covering the current Sealed Vasectomy method (8,561,615, expiring November 5, 2027) and an alternate handpiece design (8,220,464, expiring March 12, 2031). Additionally, the jaw configuration of Signatis handpiece and the two clamp configurations are covered by design patents D903867, D950055, and D886297 respectively, expiring in 2035 and 2037.
About Signati Medical
Signati Medical, Inc. is a medical device company that endeavors to take vasectomy to a new level of comfort, safety, and speed. A medical device company dedicated to advancing mens health, Signati plans to launch the first innovation in vasectomy in more than 20 years with a procedure that would be fast for physicians and comfortable for patients. The Signati Sealed Vasectomy Procedure (SVP), designed to take just minutes, could be done right in the urologists office and would offer advantages for patients including easier recovery compared to some current vasectomy techniques. To learn more, visit  .
Not approved by the Food and Drug Administration (FDA). These statements and the subject product have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. The device is not currently being marketed, nor is it available for sale in any country.

Load-Date: September 29, 2023


End of Document
